Magazine Article | January 4, 2021

Increasing Patient Diversity In Clinical Trials

Source: Life Science Leader

The COVID-19 pandemic has spotlighted healthcare’s biggest shortfalls. One of the most glaring problems sounds like it should be simple to resolve, but it has actually been challenging to implement — diversity in clinical trials.

Article written in early Nov. 2020

Appropriate demographic representation in clinical trials is finally in the spotlight as we reach closer to an approved vaccine. The development of safe and effective medicines is vital, but as an industry, broad changes and investments are needed to diversify clinical trials. Access must be expanded for individuals who have traditionally been underrepresented in clinical trials, while also partnering across patients to understand concerns, needs, and, most importantly, the barriers to and apprehensions of participating in clinical trials.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: